Safety and Feasibility of Anti-CD19 CAR-T Expressing IL-7 and CCL19 in Patients with Relapsed or Refractory Large BCell Lymphoma

doi:10.1182/blood-2022-156635

科研成果详情

题名	Safety and Feasibility of Anti-CD19 CAR-T Expressing IL-7 and CCL19 in Patients with Relapsed or Refractory Large BCell Lymphoma
作者	Lei, Wen 1; Ai, Zhao 2,3; Liu, Hui 1; Yang, Chunmei 4,5; Wei, Cheng2; Guo, Shanshan 1; Chen, Zhilu 6; Guo, Qunyi7; Li, Linjie 8; Zhao, Mingzhe 9; Wu, Gongqiang10; Zhang, Jinyi11; Gao, Jimin2,12; Qian, Wenbin 1,4
会议录名称	AMER SOC HEMATOLOGY 影响因子和分区
语种	英语
原始文献类型	Meeting Abstract
会议名称	64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)
会议日期	DEC 10-13, 2022
会议地点	New Orleans, LA
出版地	WASHINGTON
EISSN	1528-0020
卷号	140
页码	12722-12722
DOI	10.1182/blood-2022-156635
页数	1
WOS类目	Hematology
WOS研究方向	Hematology
WOS记录号	WOS:000893230305376
收录类别	SCIE ; CPCI
发表日期	2022-11-15
引用统计
文献类型	会议论文
条目标识符	https://kms.wmu.edu.cn/handle/3ETUA0LF/174909
专题	检验医学院（生命科学学院、生物学实验教学中心）其他_附属东阳医院（东阳市人民医院）其他_附属台州医院（浙江省台州医院）
作者单位	1.Zhejiang Univ, Coll Med, Affiliated Hosp 2, Dept Hematol, Hangzhou, Peoples R China; 2.Wenzhou Med Univ, Sch Lab Med & Life Sci, Minist Educ, Key Lab Lab Med, Wenzhou, Peoples R China; 3.Zhejiang Univ, Sch Med, Affiliated Hangzhou Peoples Hosp 1, Dept Geriatr, Hangzhou, Peoples R China; 4.Zhejiang Univ, Affiliated Hosp 1, Coll Med, Inst Hematol, Hangzhou, Peoples R China; 5.Zhejiang Univ, Affiliated Hosp 1, Coll Med, Dept Hematol, Hangzhou, Peoples R China; 6.Tongde Hosp Zhejiang Prov, Dept Hematol, Hangzhou, Peoples R China; 7.Taizhou Hosp Zhejiang Prov, Wenzhou Med Coll, Dept Hematol, Taizhou, Peoples R China; 8.Zhejiang Univ, Dept Hematol, Affiliated Lishui Hosp, Lishui, Peoples R China; 9.Jinhua Municipal Cent Hosp, Dept Hematol, Jinhua, Zhejiang, Peoples R China; 10.Wenzhou Med Univ, Dongyang Peoples Hosp, Dongyang Hosp, Dept Hematol, Dongyang, Peoples R China; 11.Wenzhou Med Univ, Oujiang Lab, Zhejiang Lab Regenerat Med Vis & Brain Hlth, Wenzhou, Peoples R China; 12.Hangzhou Qilan Biomed Technol Co Ltd, Hangzhou, Peoples R China
推荐引用方式 GB/T 7714	Lei, Wen,Ai, Zhao,Liu, Hui,et al. Safety and Feasibility of Anti-CD19 CAR-T Expressing IL-7 and CCL19 in Patients with Relapsed or Refractory Large BCell Lymphoma[C]. WASHINGTON,2022:12722-12722.